Clinical and Endocrine Parameters in Horses with Pituitary Pars Intermedia Dysfunction Treated with Pergolide

摘要

Pergolide is commonly used in treatment of pituitary pars intermedia dysfunction. However, there have been limited placebo-controlled trials evaluating efficacy of treatment. Furthermore, seasonal variation exists in both clinical signs and endocrinetesting results, which may impact interpretation of treatment efficacy. The purpose of this study was to evaluate the impact of pergolide on endocrine test results and intramuscular adiposity from spring (May) to early fall 0uly).